Records containing: Hypertension

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2014-07-16
  ClinicalTrials.gov study NCT00005325
• CLINICAL_TRIALS study record update · 2014-07-15
  Tailored Case Management for Diabetes and Hypertension
• CLINICAL_TRIALS study record update · 2014-07-14
  Lacidipine in Medical Practice: Incidence of Rare Adverse Drug Reactions During Long-term Treatment. 3rd Follow-up Study - Long-term Use in the 4th and 5th Year Treatment Years
• CLINICAL_TRIALS study record update · 2014-07-14
  Behavioral Treatment of High Blood Pressure
• CLINICAL_TRIALS study record update · 2014-07-14
  Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2014-07-11
  Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
• CLINICAL_TRIALS study record update · 2014-07-11
  BIBR 277 Capsules Clinical Study on Hypertension With Nephropathy
• CLINICAL_TRIALS study record update · 2014-07-11
  BIBR 277 Capsules Pharmacokinetics Study of Hypertensive Patients
• CLINICAL_TRIALS study record update · 2014-07-10
  A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
• CLINICAL_TRIALS study record update · 2014-07-09
  Free Fatty Acids-Induced Hypertension and Endothelial Dysfunction in Obese Subjects
• CLINICAL_TRIALS study record update · 2014-07-08
  A Prospective Randomised Open-Label Blinded Endpoint Trial Comparing Telmisartan 80 mg and Losartan 50 mg + Hydrochlorothiazide 12.5 mg (Fixed Dose Combination) in Patients With Mild-to-Moderate Essential Hypertension Using Ambulatory Blood Pressure Monitoring
• CLINICAL_TRIALS study record update · 2014-07-08
  An Open-Label, Six Month Safety Evaluation of the Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg in Patients With Mild-to-Moderate Hypertension
• CLINICAL_TRIALS study record update · 2014-07-08
  A Randomised, Double- Blind, Placebo-controlled, 6 Week Parallel-group Trial on the Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan 20 mg, 40 mg or 80 mg, p.o. Once Daily) or Hydrochlorothiazide 12.5 mg p.o. Once Daily in the Management of Patients With Isolated Systolic Hypertension (ISH). (ARAMIS - Study = Angiotensin II Receptor Antagonist Micardis in Isolated Systolic Hypertension)
• CLINICAL_TRIALS study record update · 2014-07-08
  A Prospective Randomized Open-Label Blinded End Point (PROBE) Trial Comparing MICARDIS® (Telmisartan) (80 mg QD) and Valsartan (80 mg QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring.
• CLINICAL_TRIALS study record update · 2014-07-08
  A Prospective Randomized Open-Label, Blinded-Endpoint (PROBE) Trial Comparing MICARDIS® (Telmisartan) (80 mg QD) and Amlodipine (5 mg QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring.
• CLINICAL_TRIALS study record update · 2014-07-08
  An Eight Week Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 40 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 40 mg
• CLINICAL_TRIALS study record update · 2014-07-08
  Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension On a Controlled Sodium Diet (100 mmol/Day)
• CLINICAL_TRIALS study record update · 2014-07-08
  A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
• CLINICAL_TRIALS study record update · 2014-07-08
  An Eight Week Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg.
• CLINICAL_TRIALS study record update · 2014-07-08
  Open-Label Follow-up Trial on Efficacy and Safety of Chronic Administration of Telmisartan 80 mg (Micardis®) Tablets as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension
• CLINICAL_TRIALS study record update · 2014-07-08
  A PROBE (Prospective, Randomised, Open-Label, Blinded Endpoint) Trial to Investigate the Efficacy and Safety of Telmisartan 40-80mg Once Daily Compared With 10-20 mg Enalapril Once Daily Over a Period of 24 Weeks in Elderly Patients With Blood Hypertension
• CLINICAL_TRIALS study record update · 2014-07-08
  A Double-blind, Parallel-group Comparison Study of BIBR 277 Capsule in Patients With Essential Hypertension
• CLINICAL_TRIALS study record update · 2014-07-08
  Safety, Tolerability and Efficacy of Micardis® (Telmisartan) in Patients With Essential Hypertension
• CLINICAL_TRIALS study record update · 2014-07-04
  A Prospective, Multi-center, Open-label, Single Arm Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II DIAbetic patieNTs With Suboptimal Blood Pressure Control (GIANT Study)
• CLINICAL_TRIALS study record update · 2014-07-04
  Effects of Intralipid and Olive Oil Infusion on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function, Autonomic Nervous System, Insulin Sensitivity and Carbohydrate Metabolism